When forecasting the company's revenue and operating income, I took into account, among other things, the stabilization of ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

These forward-looking statements include statements regarding our strategic plans, timelines and expectations with respect to sales efficacy and perceived therapeutic benefits of abecma and statements ...

Abecma US Revenue: $77 million in the third quarter, reflecting a 42% growth over the prior quarter. Projected Abecma US Revenue for 2024: Approximately $240 to $250 million. Collaboration Arrangement ...

TD Cowen analyst Yaron Werber maintained a Hold rating on 2seventy bio (TSVT – Research Report) today. The company’s shares closed ...

Seventy Bio, Inc. ( (TSVT) ) has released its Q3 earnings. Here is a breakdown of the information 2Seventy Bio, Inc. presented to its ...

News release. Janssen. February 28, 2022. https://bit.ly/35yWwjv U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s ...